Fresenius Medical Care | FME - Ebit

Aktienkurs
39.78
Täglich Wechseln
0.01 0.03%
Monatlich
-2.71%
Jährlich
-9.73%
Q1 Prognose
38.69




Ebit Veränderung Datum
Akzo Nobel EUR 217M 80M 2025-12
Alcon AG USD 317M 17M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Beiersdorf EUR 504M 312M 2025-12
DaVita Healthcare Partners USD 584.2M 124.84M 2025-12
Demant DKK 2.07B 201M 2025-12
E.ON EUR 1.06B 349M 2025-12
Essilor EUR 1.38B 626M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Genmab DKK 432M 900.27M 2025-06
Getinge SEK 2.02B 1.2B 2024-12
Givaudan CHF 756M 221M 2024-06
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GN Store Nord DKK 570M 230M 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Lonza CHF 673M 54M 2025-06
Merck EUR 474M 738M 2025-12
Novartis USD -9.19B 13.87B 2025-06
Philips EUR 719M 390M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
RWE EUR 1.43B 791M 2025-09
Sanofi EUR 1.7B 2.17B 2025-12
SAP EUR 2.78B 1.95B 2025-12
Smith & Nephew USD 440M 50M 2025-12